Month: June 2020

GOFORE PLC COMPANY ANNOUNCEMENT 30 JUNE 2020 AT 14.00  According to the incentive program targeted at Silver Planet Oy personnel a total of 24,154 Gofore shares were granted without compensation to Silver Planet Oy personnel on 28 April, 2020.

GOFORE OYJ YHTIÖTIEDOTE 30.6.2020 KLO 14.00  Gofore on saanut päätökseen omien osakkeidensa hankinnan, jonka aloittamisesta yhtiö tiedotti 24.3.2020. Yhtiö hankki 26.3.-30.6.2020 yhteensä 57 839 omaa osaketta keskihintaan 7,08 euroa osakkeelta. Osakkeet hankittiin Nasdaq Helsinki Oy:n järjestämässä julkisessa kaupankäynnissä hankintahetken markkinahintaan. Omien osakkeiden hankinta perustui varsinaisen yhtiökokouksen 26.3.2019 antamaan valtuutukseen ja osakkeet käytetään vastikkeena mahdollisissa yrityskaupoissa, osana yhtiön osakepohjaisia kannustinjärjestelmiä sekä muutoin edelleen luovutettavaksi, yhtiöllä pidettäväksi tai mitätöitäväksi.  Silver Planet Oy:n henkilöstölle suunnatun kannustinohjelman myötä heille luovutettiin 28.4.2020 vastikkeetta yhteensä 24 154 Goforen osaketta.Hankintaohjelman päätyttyä Gofore Oyj:llä on yhteensä...

STAMFORD, Conn., June 30, 2020 (GLOBE NEWSWIRE) — Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors, or KORs, today announced the appointment of Susan Shiff, Ph.D., M.B.A., to its Board of Directors. Dr. Shiff currently serves as Senior Vice President and Head of the Center for Observational and Real-World Evidence (CORE) at Merck, known as MSD outside the United States and Canada.“Susan brings a wealth of experience in the health economics and outcomes research (HEOR) and market access fields, and joins the Board at a pivotal time as we prepare to transition to a commercial organization,” said Derek Chalmers, Ph.D., D.Sc., President and Chief Executive Officer...

MONTREAL, June 30, 2020 (GLOBE NEWSWIRE) — Goodfood Market Corp. (“Goodfood” or “the Company”) (TSX:FOOD), a leading online grocery Company in Canada, will release its financial results for the third quarter of Fiscal 2020 on Wednesday, July 8, 2020, before markets open. Jonathan Ferrari, CEO, Neil Cuggy, President and COO, and Philippe Adam, CFO, will hold a conference call to review the results at 8:00 a.m. (ET) on the same day.Details of the Conference Call:When: July 8, 2020 at 8:00 a.m. ETDial in number: 877-223-4471 or 647-788-4922Conference call replay available until July 15, 2020:1-800-585-8367 or 416-621-4642To access the webcast and view the slide presentation, click on this link:https://www.makegoodfood.ca/en/investisseurs/evenementsThe conference ID is 3298385.About GoodfoodGoodfood (TSX:FOOD) is a leading online grocery...

MONTRÉAL, 30 juin 2020 (GLOBE NEWSWIRE) — Marché Goodfood Corp. (« Goodfood » ou la « Société ») (TSX : FOOD), un chef de file canadien de l’épicerie en ligne, publiera ses résultats financiers pour le troisième trimestre de l’exercice financier 2020 le mercredi 8 juillet 2020, avant l’ouverture des marchés financiers. Jonathan Ferrari, chef de la direction, Neil Cuggy, président et chef des opérations, et Philippe Adam, chef de la direction financière, tiendront une conférence téléphonique à 8H00 (HE) le jour même pour présenter les résultats de la Société.Renseignements sur la conférence téléphonique :Quand : Le 8 juillet 2020 à 8H00 (HE)Numéro à composer : 877-223-4471 ou 647-788-4922Enregistrement de la conférence disponible jusqu’au 15 juillet 2020 :1-800-585-8367 ou 416-621-4642Pour écouter la conférence et visionner la présentation,...

IQE plcTotal Voting Rights and Block Admission Return30 June 2020(“IQE” or the “Company”)Total Voting Rights:As at 30 June 2020, the Company’s issued share capital consisted of 796,815,887 ordinary shares of 1 pence each (“Ordinary Shares”). All of these Ordinary Shares carry voting rights of one vote per Ordinary Share. The Company holds no Ordinary Shares in treasury.The total number of voting rights in the Company is therefore 796,815,887.The above figures  may  be  used  by  shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules.Block Admission Return:The company hereby provides an update to its block admission filed on 21 January...

THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND IS NOT AN OFFER OF SECURITIES IN ANY JURISDICTIONAMRYT PHARMA PLC(“Amryt” or the “Company”)POSTING OF ANNUAL REPORT AND NOTICE OF AGMDUBLIN, Ireland, and Boston MA, June 30, 2020, Amryt Pharma (AIM: AMYT, Euronext Growth: AYP), a global, commercial-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat patients suffering from serious and life-threatening rare diseases, announces that copies of the 2019 Annual Report have been sent to shareholders along with the Notice of Annual General Meeting (“AGM”). Copies are also available from the Company’s website, www.amrytpharma.com.AGM Arrangements – The Company’s AGM will be held at the Company’s headquarters at 90 Harcourt Street, Dublin 2, Ireland at 12.30 p.m. on Wednesday,...

Aspo PlcManagers’ transactionsJune 30, 2020 at 2 p.m. Aspo Plc – Managers’ transactions – Aki OjanenPerson subject to the notification requirementName: Ojanen AkiPosition: Chief Executive OfficerIssuer: Aspo OyjLEI: 7437000TB0GHDHLPX677Notification type: INITIAL NOTIFICATIONReference number: 7437000TB0GHDHLPX677_20200630110441_6____________________________________________Transaction date: 2020-06-29Venue not applicableInstrument type: SHAREISIN: FI0009008072Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE OR REMUNERATIONTransaction details(1): Volume: 40,000 Unit price: 0.00000 EURAggregated transactions(1): Volume: 40,000 Volume weighted average price: 0.00000 EURASPO PlcFor further information, please contact: Arto Meitsalo, CFO, tel. +358 40 551 1422, arto.meitsalo@aspo.com

— Submission based on world’s largest database of patients treated for spasticity associated with Multiple Sclerosis —— Demonstrated efficacy, tolerability and one-year safety results on 80 mg/day —BRIDGEWATER, N.J., June 30, 2020 (GLOBE NEWSWIRE) — Osmotica Pharmaceuticals plc (Nasdaq: OSMT) through its subsidiary Osmotica Pharmaceutical US LLC (“Osmotica” or the “Company”), a fully integrated biopharmaceutical company, announced today that the Company has resubmitted its New Drug Application (“NDA”) for arbaclofen extended release (“ER”) tablets for the alleviation of spasticity in Multiple Sclerosis (“MS”) patients to the U.S. Food and Drug Administration (“FDA”).“We are excited to have resubmitted our NDA for arbaclofen ER, our novel treatment, using the Osmodex technology, for MS spasticity. With the...

CHICAGO, June 30, 2020 (GLOBE NEWSWIRE) — TransUnion (NYSE: TRU) will publish its financial results for the second quarter ending June 30, 2020, in a press release to be issued by 6:00 a.m. Central Time (CT) on Tuesday, July 28, 2020. The company will hold a conference call on the same day at 8:00 a.m. Central Time (CT) to discuss its financial results. The press release and a live webcast of the earnings conference call will be available on the TransUnion Investor Relations website at http://www.transunion.com/tru.About TransUnionTransUnion is a global information and insights company that makes trust possible in the modern economy. We do this by providing a comprehensive picture of each person so they can be reliably and safely represented in the marketplace. As a result, businesses and consumers can transact with confidence and...